Doctors track how COPD patients feel on new triple therapy
NCT ID NCT06368427
Summary
This study observed how patients with moderate to severe COPD felt after starting a standard triple-inhaler medication (BGF MDI) in everyday Romanian clinics. It followed 10 patients for up to 6 months, primarily tracking changes in their self-reported health status and treatment satisfaction. The goal was to understand the real-world experience with this existing treatment, not to test a new cure.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Research Site
Baia Mare, Romania
-
Research Site
Bucharest, Romania
-
Research Site
Cluj-Napoca, Romania
-
Research Site
Constanța, Romania
-
Research Site
Craiova, Romania
-
Research Site
Deva, Romania
-
Research Site
Dorohoi, Romania
-
Research Site
Hunedoara, Romania
-
Research Site
Iași, Romania
-
Research Site
Luduş, Romania
-
Research Site
Medgidia, Romania
-
Research Site
Oradea, Romania
-
Research Site
Sighișoara, Romania
-
Research Site
Suceava, Romania
-
Research Site
Târgu Mureş, Romania
-
Research Site
Timișoara, Romania
Conditions
Explore the condition pages connected to this study.